UCLA Study Assesses Cost-Effectiveness of Hepatitis B Drugs
University of California, Los Angeles (UCLA), Health SciencesUCLA researchers conducted the largest most comprehensive study comparing the cost-effectiveness of current modern drugs for treating hepatitis B -- a disease affecting 350 million worldwide.